The Mayo Clinic (Rochester, MD) and Gentag Inc (Washington, DC, USA) have joined forces to develop the next generation of wearable biosensors designed to fight obesity and diabetes.
The first-of-a-kind, wearable patch sensors are the size of a small bandage and are designed to be painless, wireless and disposable. The bandage contains a sensor that communicates via a closed-loop diabetes management system which is compatible with cell phones. In addition to monitoring blood glucose levels, the system will allow researchers to monitor movement and develop treatments for obesity and related conditions.
Under a joint intellectual property agreement, over 50 issued patents and technologies are being offered for licensing under the agreement. James Levine, a Mayo Clinic endocrinologist and obesity researcher, said: “We are hoping that this technology will be game-changer. These patch biosensors may help us reduce global obesity and diabetes. They are accurate, inexpensive, and can be integrated into the care people receive.”
More information about the partnership can be found here.
